Note: Ingredients listed on restricted chemical lists
EC/CAS
204-658-1/123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
10-<25
General Information
Revision date
2023-05-10
Product name
8671-0908
supplier name
Tarka, Malgorzata
Manufacturer Name
Carboline Norge AS
Emergency telephone
+1 703 5273887 (Outside US
Icons in SDS
Company Information
company name
Carboline Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
hms@carboline.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H317, H332, H335, H336
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Hazard statements
Skin Cracking EUH066 EU Other EUH204 Flam. Liq. 3 H226 Skin Sens. 1 H317 Acute Tox. 4 Inhalation H332 STOT SE 3 RTI H335 STOT SE 3 NE H336 Skin Cracking EUH066 Repeated exposure may cause skin dryness or cracking. EU Other EUH204 Contains isocyanates. May produce an allergic reaction. Flam. Liq. 3 H226 Flammable liquid and vapour. Skin Sens. 1 H317 May cause an allergic skin reaction. Acute Tox. 4 Inhalation H332 Harmful if inhaled. STOT SE 3 RTI H335 May cause respiratory irritation. STOT SE 3 NE H336 May cause drowsiness or dizziness.
2.2 Label elements
Symbol(s) of Product
Signal word
Warning Named Chemicals on Label n-butyl acetate, hexamethylene diisocyanate, oligomers
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/ face protection. P284 Wear respiratory protection. P302+352 IF ON SKIN: Wash with plenty of soap and water. P304+340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+313 If skin irritation or rash occurs: Get medical advice/attention.
Additional information
ADD-020 Content of hexamethylene diisocyanate (CAS-no 822-06-0): <0.1%.
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/vPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher. Endocrine disrupting properties - Ecotoxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher.
